Fiche société
Guangzhou Magpie Pharmaceuticals Co., Ltd.
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBNThe purpose of this study is to assess the safety, tolerability and pharmacokinetics (i.e. how study drug is taken up by the body) of TBN in healthy participants. | Sclérose latérale amyotrophique | Phase 1 | À vérifier | À vérifier | |
| A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBNThe purpose of this study is to assess the safety, tolerability and pharmacokinetics (i.e. how study drug is taken up by the body) of TBN in healthy participants. | Sclérose latérale amyotrophique | Phase 1 | À vérifier | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN | Sclérose latérale amyotrophique | Phase 1 | NCT04667013 | A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN | NOT_YET_RECRUITING |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||